Samer Ellahham, M.D. and Helmy M. Siragy, M.D.
Dr. Ellahham is Head, The Center for Heart Failure, Department of Cardiac Sciences, SKMC/Cleveland Clinic Foundation, Abu Dhabi, UAE, and Dr. Siragy is Professor of Medicine and Endocrinology, Department of Medicine, and Director, Hypertension Center, The University of Virginia, Charlottesville, Virginia, USA.
Within the past 12 months, Dr. Ellahham reports no commercial conflicts of interest and Dr. Siragy reports no commercial conflicts of interest.
Albert Einstein College of Medicine, CCME staff and interMDnet staff have nothing to disclose.
Estimated course time: 1 hour(s).
Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Upon completion of this Cyberounds®, you should be able to:
Describe the importance of blood pressure lowering for the prevention of cardiovascular complications
Discuss the role of the renin-angiotensin-Aldosterone system (RAS) in development of hypertension
Describe the mechanisms involved with different inhibitors of the RAS
Discuss the recent data of the blood pressure-lowering effects achieved through renin inhibition.
